NCT06895460View on ClinicalTrials.gov

A Trial on the Treatment of Bronchial Asthma With Budesonide Formoterol Combined With Immune Modulators (Staphylococcus and Neisseria Tablets)

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

198

Participants

Timeline

Start Date

June 20, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

September 30, 2027

Conditions
Bronchial Asthma
Interventions
DRUG

Budesonide Formoterol

Investigator Selection

DRUG

Placebo

Placebo: 0.3 mg/tablet, 4 tablets per dose, 3 times per day, for a course of 3 months

DRUG

Immune Modulators (Staphylococcus and Neisseria Tablets)

Staphylococcus and Neisseria Tablets: 0.3 mg/tablet, 4 tablets per dose, 3 times per day, for a course of 3 months

Trial Locations (1)

210000

The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, Nanjing

All Listed Sponsors
lead

The First Affiliated Hospital with Nanjing Medical University

OTHER